finasteride has been researched along with Psychotic Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bini, V; Bortolato, M; Caruso, D; Devoto, P; Fanni, S; Frau, R; Marrosu, F; Pardu, A; Puligheddu, M; Roncada, P; Scheggi, S; Soggiu, A | 1 |
| Bortolato, M; Bourov, Y; Devoto, P; Frau, R; Gessa, GL; Marrosu, F; Mereu, G; Orrù, M | 1 |
| Bortolato, M; Koethe, D; Leweke, FM; Piomelli, D | 1 |
3 other study(ies) available for finasteride and Psychotic Disorders
| Article | Year |
|---|---|
The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.
Topics: 5-alpha Reductase Inhibitors; Acoustic Stimulation; Animals; Antipsychotic Agents; Brain; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Dose-Response Relationship, Drug; Finasteride; Gene Expression Regulation, Enzymologic; Male; Pregnanolone; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sleep Deprivation; Steroids | 2017 |
Antipsychotic-like properties of 5-alpha-reductase inhibitors.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androstanes; Animals; Antipsychotic Agents; Azasteroids; Brain; Disease Models, Animal; Dopamine Agonists; Dutasteride; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Finasteride; Gonadal Steroid Hormones; Hyperkinesis; Male; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sensory Gating; Stereotyped Behavior; Testosterone; Treatment Outcome | 2008 |
Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report.
Topics: Adult; Chronic Disease; Cognition; Enzyme Inhibitors; Finasteride; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Social Behavior | 2008 |